Takayasu Arteritis
Symptoms, Doctors, Treatments, Advances & More

Learn About Takayasu Arteritis

What is the definition of Takayasu Arteritis?

Takayasu arteritis is an inflammation of large arteries such as the aorta and its major branches. The aorta is the artery that carries blood from the heart to the rest of the body.

What are the alternative names for Takayasu Arteritis?

Pulseless disease; Large-vessel vasculitis

What are the causes of Takayasu Arteritis?

The cause of Takayasu arteritis is not known. The disease occurs mainly in women between the ages of 20 and 40 years old. It is more common in people of East Asian, Indian or Mexican descent. However, it is now being seen more often in other parts of the world. Several genes that increase the chance of having this problem were recently found.

Takayasu arteritis appears to be an autoimmune condition. This means the body's immune system mistakenly attacks healthy tissue in the blood vessel wall. The condition may also involve other organ systems.

This condition has many features that are similar to giant cell arteritis or temporal arteritis in older people.

What are the symptoms of Takayasu Arteritis?

Symptoms may include:

  • Arm weakness or pain with use
  • Chest pain
  • Dizziness
  • Fatigue
  • Fever
  • Lightheadedness
  • Muscle or joint pain
  • Skin rash
  • Night sweats
  • Vision changes
  • Weight loss
  • Decreased radial pulses (at the wrist)
  • Difference in blood pressure between the two arms
  • High blood pressure (hypertension)

There may also be signs of inflammation (pericarditis or pleuritis).

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Takayasu Arteritis?

Treatment of Takayasu arteritis is difficult. However, people who have the right treatment can improve. It is important to identify the condition early. The disease tends to be chronic, requiring long-term use of anti-inflammatory medicines.

MEDICINES

Most people are first treated with high doses of corticosteroids such as prednisone. As the disease is controlled the dose of prednisone is decreased.

In almost all cases, immunosuppressive medicines are added to reduce the need for long-term use of corticosteroids and yet maintain control of the disease.

Conventional immunosuppressive medicines such as methotrexate, azathioprine, mycophenolate, cyclophosphamide, or leflunomide are often added.

Biologic medicines may also be effective. These include TNF inhibitors such as infliximab, etanercept, and tocilizumab.

SURGERY

Surgery or angioplasty may be used to open up narrowed arteries to supply blood or open up the constriction.

Aortic valve replacement may be needed in some cases.

Who are the top Takayasu Arteritis Local Doctors?
Elite in Takayasu Arteritis
Rheumatology
Elite in Takayasu Arteritis
Rheumatology
Referral required

Johns Hopkins Bayview Medical Center

Baltimore, MD 
Languages Spoken:
English, French, Spanish
Accepting New Patients
Offers Telehealth

Philip Seo is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Seo is rated as an Elite provider by MediFind in the treatment of Takayasu Arteritis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Seo is board certified in American Board Of Internal Medicine. Dr. Seo is currently accepting new patients.

Elite in Takayasu Arteritis
Elite in Takayasu Arteritis
Referral may be required

Uchealth Hand Clinic-Anschutz Medical Campus

1635 Aurora Ct, 
Aurora, CO 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Larry Moreland is a Rheumatologist practicing medicine in Aurora, Colorado. Dr. Moreland is rated as an Elite provider by MediFind in the treatment of Takayasu Arteritis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Vasculitis, Granulomatosis with Polyangiitis, Rheumatoid Arthritis (RA), Arthritis, and Knee Replacement. Dr. Moreland is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Takayasu Arteritis
Elite in Takayasu Arteritis
Referral may be required

Mayo Clinic-Rochester

5716 Cleveland St Ste 200, 
Virginia Beach, VA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kenneth Warrington is a Rheumatologist practicing medicine in Virginia Beach, Virginia. Dr. Warrington is rated as an Elite provider by MediFind in the treatment of Takayasu Arteritis. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Temporal Arteritis, Giant Cell Arteritis (GCA), Vasculitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Warrington is currently accepting new patients.

What is the outlook (prognosis) for Takayasu Arteritis?

This disease can be fatal without treatment. However, a combined treatment approach using medicines and surgery has reduced death rates. Adults have a better chance of survival than children.

What are the possible complications of Takayasu Arteritis?

Complications may include:

  • Blood clot
  • Heart attack
  • Heart failure
  • Pericarditis
  • Aortic valve insufficiency
  • Pleuritis
  • Stroke
  • Gastrointestinal bleeding or pain from blockage of bowel blood vessels
When should I contact a medical professional for Takayasu Arteritis?

Contact your health care provider if you have symptoms of this condition. Immediate care is needed if you have:

  • Weak pulse
  • Chest pain
  • Breathing difficulty
What are the latest Takayasu Arteritis Clinical Trials?
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people's genes and follow people over time to see how the disease affects them.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine (Butantan-DV) in Patients With Autoimmune Rheumatic Diseases Living in Dengue-Endemic Areas

Summary: The goal of this clinical trial is to evaluate whether the live attenuated tetravalent Butantan-Dengue vaccine (Butantan-DV) is safe and capable of inducing an immune response in patients aged 12 to 59 years with autoimmune rheumatic diseases (ARDs) who are clinically stable and under low-grade or no immunosuppression, as well as in healthy volunteers matched by sex and age. The main questions it ...

What are the Latest Advances for Takayasu Arteritis?
The eye in systemic vasculitis.
Tired of the same old research?
Check Latest Advances
Updated 2026 Japanese Diagnostic Criteria for Takayasu Arteritis.
Who are the sources who wrote this article ?

Published Date: October 09, 2025
Published By: Diane M. Horowitz, MD, Rheumatology and Internal Medicine, Northwell Health, Great Neck, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Beckman JA. Diseases of the aorta. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 63.

Ehlert BA. Takayasu disease. In: Sidawy AN, Perler BA, eds. Rutherford's Vascular Surgery and Endovascular Therapy. 10th ed. Philadelphia, PA: Elsevier; 2023:chap 140.

Miller JB, Hellmann DB. Giant cell arteritis, polymyalgia rheumatica, and Takayasu's arteritis. In: Firestein GS, McInnes IB, Koretzky GA, Mikuls TR, Neogi T, O'Dell JR, eds. Firestein & Kelley's Textbook of Rheumatology. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 89.